Association between smoking status, and free, total and percent free prostate specific antigen
- PMID: 22335864
- PMCID: PMC4479165
- DOI: 10.1016/j.juro.2011.11.086
Association between smoking status, and free, total and percent free prostate specific antigen
Abstract
Purpose: There are scant data available on the relationship between smoking and total prostate specific antigen, free prostate specific antigen and percent-free prostate specific antigen. Given the high prevalence of smoking and the frequency of prostate specific antigen screening, it is important to determine any association between smoking and prostate specific antigen values using nationally representative data.
Materials and methods: Included in the final study population were 3,820 men 40 years old or older who participated in the 2001-2006 NHANES (National Health and Nutrition Examination Survey) and met the eligibility criteria for prostate specific antigen testing. The distributions of total, free and percent free prostate specific antigen were estimated by sociodemographic and clinical characteristics. Multivariate linear regression models were fit to determine the adjusted relationship between smoking and total and percent free prostate specific antigen while simultaneously controlling for these characteristics.
Results: For all ages combined the median total and free prostate specific antigen levels were 0.90 (0.81-0.90) and 0.26 (0.25-0.28) ng/ml, respectively. Multivariate linear regression analysis showed that total prostate specific antigen was 7.9% and 12.2% lower among current and former smokers, respectively, than among never smokers. High body mass index and diabetes were also statistically significantly associated with a lower total prostate specific antigen. Approximately a third of the men had a percent free prostate specific antigen less than 25%. Current smokers had a significantly lower percent free prostate specific antigen than former smokers.
Conclusions: Our finding that smoking is inversely associated with total prostate specific antigen may have potential implications for the interpretation of prostate specific antigen levels in men who are current or former smokers. Given the high prevalence of smoking, obesity and diabetes, additional research on the combined effect of these health risk factors is warranted.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1056-62. doi: 10.1016/j.ijrobp.2003.08.021. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001245
-
Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.Urology. 2010 Nov;76(5):1042-6. doi: 10.1016/j.urology.2009.05.100. Epub 2009 Sep 25. Urology. 2010. PMID: 19781743
-
Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002.Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2178-82. doi: 10.1158/1055-9965.EPI-05-0206. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16172229
-
Health risk behaviors and prostate specific antigen awareness among men in California.J Urol. 2008 Aug;180(2):658-62; discussion 662. doi: 10.1016/j.juro.2008.04.007. Epub 2008 Jun 12. J Urol. 2008. PMID: 18554651 Free PMC article.
-
The use of percent free prostate specific antigen for staging clinically localized prostate cancer.J Urol. 1998 Apr;159(4):1238-42. J Urol. 1998. PMID: 9507844 Review.
Cited by
-
Elevation of Serum Prostate-Specific Antigen Levels in Males With Pulmonary Embolism.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241250002. doi: 10.1177/10760296241250002. Clin Appl Thromb Hemost. 2024. PMID: 38779806 Free PMC article.
-
Cigarette Smoking, Alcohol Consumption, and the Risk of Prostate Cancer-A Retrospective Analysis of Prostate Cancer Patients in Southern Nigeria.Niger Med J. 2022 May 28;62(6):346-352. doi: 10.60787/NMJ-62-6-66. eCollection 2021 Nov-Dec. Niger Med J. 2022. PMID: 38736515 Free PMC article.
-
Advances and development of prostate cancer, treatment, and strategies: A systemic review.Front Cell Dev Biol. 2022 Sep 9;10:991330. doi: 10.3389/fcell.2022.991330. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36158198 Free PMC article. Review.
-
Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.Sci Rep. 2022 Jan 7;12(1):55. doi: 10.1038/s41598-021-04116-8. Sci Rep. 2022. PMID: 34997089 Free PMC article.
-
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study.Future Sci OA. 2021 Jan 12;7(3):FSO643. doi: 10.2144/fsoa-2020-0154. Future Sci OA. 2021. PMID: 33552540 Free PMC article. Review.
References
-
- Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320. - PubMed
-
- Stephenson RA. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am. 2002;29:173. - PubMed
-
- Partin AW, Catalona WJ, Southwick PC, et al. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology. 1996;48:55. - PubMed
-
- Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA. 1993;270:860. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
